Evidence map›Paper›PMID 17635959›Full record

ArticleThe Journal of general physiology2007

Structural basis of GLUT1 inhibition by cytoplasmic ATP.

David M Blodgett, Julie K De Zutter, Kara B Levine, Pusha Karim, Anthony Carruthers

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The novel family of WarbicinFrontiers in oncology · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Glucose transporters in pancreatic islets.Pflugers Archiv : European journal of physiology · 2020
    Review
  12. Article
  13. Article
  14. Affinity and path of binding xylopyranose unto E. coli xylose permease.Biochemical and biophysical research communications · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. How does the chemical potential of the substrate drive a uniporter?Protein science : a publication of the Protein Society · 2016
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David M BlodgettDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Julie K De Zutter
Kara B Levine
Pusha Karim
Anthony Carruthers
University of Massachusetts Chan Medical School · US

Funding

SUGAR TRANSPORTER OLIGOMERIC STRUCTURE AND FUNCTIONR01DK044888 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CARRUTHERS, ANTHONY · 1992 to 2016
$4.2M
METABOLIC CONTROL OF SUGAR TRANSPORTR01DK036081 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CARRUTHERS, ANTHONY · 1986 to 2012
$3.4M
Metabolic control of sugar transportR56DK036081 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CARRUTHERS, ANTHONY · 2007 to 2007
$266k
NIDDK NIH HHS DK 36081NIDDK NIH HHS DK 44888NIDDK NIH HHS R01 DK036081NIDDK NIH HHS R01 DK044888NIDDK NIH HHS R56 DK036081
6 · The paper itself

Abstract

Cytoplasmic ATP inhibits human erythrocyte glucose transport protein (GLUT1)-mediated glucose transport in human red blood cells by reducing net glucose transport but not exchange glucose transport (Cloherty, E.K., D.L. Diamond, K.S. Heard, and A. Carruthers. 1996. Biochemistry. 35:13231-13239). We investigated the mechanism of ATP regulation of GLUT1 by identifying GLUT1 domains that undergo significant conformational change upon GLUT1-ATP interaction. ATP (but not GTP) protects GLUT1 against tryptic digestion. Immunoblot analysis indicates that ATP protection extends across multiple GLUT1 domains. Peptide-directed antibody binding to full-length GLUT1 is reduced by ATP at two specific locations: exofacial loop 7-8 and the cytoplasmic C terminus. C-terminal antibody binding to wild-type GLUT1 expressed in HEK cells is inhibited by ATP but binding of the same antibody to a GLUT1-GLUT4 chimera in which loop 6-7 of GLUT1 is substituted with loop 6-7 of GLUT4 is unaffected. ATP reduces GLUT1 lysine covalent modification by sulfo-NHS-LC-biotin by 40%. AMP is without effect on lysine accessibility but antagonizes ATP inhibition of lysine modification. Tandem electrospray ionization mass spectrometry analysis indicates that ATP reduces covalent modification of lysine residues 245, 255, 256, and 477, whereas labeling at lysine residues 225, 229, and 230 is unchanged. Exogenous, intracellular GLUT1 C-terminal peptide mimics ATP modulation of transport whereas C-terminal peptide-directed IgGs inhibit ATP modulation of glucose transport. These findings suggest that transport regulation involves ATP-dependent conformational changes in (or interactions between) the GLUT1 C terminus and the C-terminal half of GLUT1 cytoplasmic loop 6-7.

Indexed as

Adenosine TriphosphateAmino AcidsBiological TransportCytoplasmErythrocytesGlucoseGlucose Transporter Type 1HumansProtein BindingProtein ConformationAdenosine TriphosphateAmino AcidsGlucoseGlucose Transporter Type 1SLC2A1 protein, human

Identifiers

PMID17635959
PMCPMC2031153
OpenAlexW2162272218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.